Hagop Kantarjian, MD #SOHO2019

23:11

Presentation on AML: Selecting Therapy for Newly Diagnosed Patients presented at the 2019 SOHO Conference.

Acute Myeloid Leukemia

Presentation on AML: Selecting Therapy for Newly Diagnosed Patients presented at the 2019 SOHO Conference.

Acute Myeloid Leukemia Similar Videos

Similar Videos

Advances in biomarker-driven therapy in AML_Eunice Wang, MD; #BeyondASCO

15:08
What’s New in Upfront Treatment of AML?_Joseph Jurcic, MD; #hemeupdates2022

14:44
New Directions in the Treatment of Relapsed and Refractory AML_Gail Roboz, MD; #hemeupdates2022

12:35

ABOUT

Bio Ascend is an independent medical education company committed to supporting healthcare providers in their efforts to translate innovative science into clinical practice.

The Bio Ascend team has deep oncology and hematology expertise with a proven ability to distill complex scientific ideas into their essential components, as well as extensive experience in planning, executing, and assessing meaningful education for clinicians.

CONNECT

support@bioascend.com

(888) 476-9129

980 North Michigan Avenue, Suite 1400, Chicago, IL 60611